Prophylactic therapy for selective IgA deficiency [6]

Lancet

Volumn 350, Issue 9081, 1997, Pages 865-

  Gustafson, R ^a   Gardulf, A ^a   Granert, C ^a   Hansen, S ^a   Hammarstrom L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMANORM; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; BACTERIAL INFECTION; CLINICAL ARTICLE; DRUG CONTRAINDICATION; DRUG EFFICACY; HEADACHE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; LETTER; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY TRACT INFECTION; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; VERTIGO;

EID: 0342506487     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62034-X     Document Type: Article

References (5)

1. Buckley RH. Clinical and immunologic features of selective IgA deficiency. Birth Defects 1975; 11: 134-42.
2. Oxelius V-A, Laurell A-B, Lindquist B, et al. IgG subclasses in selective IgA deficiency - importance of IgG2-IgGA deficiency. N Engl J Med 1981; 304: 1476.
3. Hammarström L, Persson MAA, Smith CIE. Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors. Immunology 1985; 54: 821-26.
4. Gardulf A, Hammarström L, Smith CIE. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991; 338: 162-66.
5. Gardulf A, Andersen V, Björkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 1995; 345: 365-69.